CIA
TECH icon

Choate Investment Advisors’s Bio-Techne TECH Stock Holding History

Choate Investment Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Sell
19,425
-102
-0.5% -$5.51K 0.02% 211
2026
Q1 		$1.02M Hold
19,527
– – 0.02% 232
2025
Q4 		$1.15M Buy
+19,527
New +$1.19M 0.02% 215

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Choate Investment Advisors's TECH Position: Q2 2026 in Review

Choate Investment Advisors reduced its Bio-Techne (TECH) stake by 0.52% in Q2 2026, selling an estimated $5.51K and leaving 19,425 shares worth $1.37M. The position accounts for 0.02% of the portfolio, ranked #211.

Choate Investment Advisors first reported a position in TECH in Q4 2025 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Choate Investment Advisors held 19,425 shares of Bio-Techne worth $1.37M as of Q2 2026.
  • Choate Investment Advisors sold 102 Bio-Techne shares in Q2 2026, an estimated $5.51K.
  • Bio-Techne made up 0.02% of Choate Investment Advisors's portfolio in Q2 2026, its #211 holding.
  • Choate Investment Advisors first reported a position in Bio-Techne in Q4 2025 and has held it in 3 quarters since.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Choate Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.